Literature DB >> 26117335

The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.

Clémentine Gamonet1, Marina Deschamps1, Sandrine Marion2, Georges Herbein3, Gilles Chiocchia2, Isabelle Auger4, Philippe Saas5, Christophe Ferrand6, Eric Toussirot7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26117335     DOI： 10.1093/rheumatology/kev210

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  2 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

2.  New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Authors:  Clémentine Gamonet; Elodie Bole-Richard; Aurélia Delherme; François Aubin; Eric Toussirot; Francine Garnache-Ottou; Yann Godet; Loïc Ysebaert; Olivier Tournilhac; Dartigeas Caroline; Fabrice Larosa; Eric Deconinck; Philippe Saas; Christophe Borg; Marina Deschamps; Christophe Ferrand
Journal:  Exp Hematol Oncol       Date:  2016-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.